论文部分内容阅读
对30例原发性肝癌患者进行49人次肝动脉灌注化疗和栓塞。19例作灌注化疗加明胶海绵栓塞综合治疗,栓塞后造影可见周围或近端肝动脉栓塞,随访性血管造影见肿瘤血管减少或完全消失,肿瘤缩小,肿瘤坏死区扩大;另11例作单纯性灌注。所有栓塞的病例均有栓塞后综合征,平均存活期半年。灌注化疗加栓塞综合治疗优于单纯性灌注化疗。本文就肝动脉灌注化疗和栓塞的治疗价值、栓塞后综合征、并发症和禁忌症及影响治疗的因素进行讨论。
Thirty-nine patients with primary liver cancer were treated with hepatic arterial infusion chemotherapy and embolization for 49 times. 19 cases were treated with infusion chemotherapy plus gelatin sponge embolization. Peripheral or proximal hepatic arterial embolization was seen after embolization. Follow-up angiography showed reduction or complete disappearance of tumor vasculature, tumor shrinkage, and enlarged tumor necrosis area; another 11 cases were simple. perfusion. All embolism cases had postembolization syndrome and the average survival period was six months. Perfusion chemotherapy plus embolization combined treatment is superior to simple perfusion chemotherapy. This article discusses the therapeutic value of hepatic arterial infusion chemotherapy and embolization, post-embolus syndrome, complications, contraindications, and factors influencing treatment.